Document:

EX-10.1

 Exhibit 10.1 

RESTRICTED STOCK UNIT AWARD AGREEMENT 

UNDER THE AMENDED AND RESTATED 

DESTINATION MATERNITY CORPORATION 

2005 EQUITY INCENTIVE PLAN 

THIS RESTRICTED STOCK UNIT AWARD AGREEMENT (this “Agreement”) is made by and between Destination Maternity Corporation, a
Delaware corporation, (the “Company”) and                      (the “Grantee”). 

WHEREAS, the Company maintains the Amended and Restated Destination Maternity Corporation 2005 Equity Incentive Plan (the
“Plan”) for the benefit of its employees, directors, consultants, and other individuals who provide services to the Company; and 

WHEREAS, the Plan permits the grant of Restricted Stock Units, including Restricted Stock Units that are Performance Awards; and 

WHEREAS, to compensate the Grantee for his or her service with the Company and to further align the Grantee’s financial interests with
those of the Company’s other stockholders, the Board approved this Award of Restricted Stock Units effective on                  ,      (the
“Effective Date”). 
 NOW, THEREFORE, in consideration of these premises and the agreements set forth herein, the parties,
intending to be legally bound hereby, agree as follows: 
 1. Award of Performance-Based Restricted Stock Units. 

(a) Award. The Company hereby awards the Grantee
                     Restricted Stock Units (the “Target Award”), subject to adjustment as set forth in Section 5 of this
Agreement and Section 3(c) of the Plan and subject further to the restrictions and on the terms and conditions set forth in this Agreement (the “Restricted Stock Units”). The terms of the Plan are hereby incorporated into this
Agreement by this reference, as though fully set forth herein. Except as otherwise provided herein, capitalized terms herein will have the same meaning as defined in the Plan. 

(b) Performance Restricted Stock Units. The Restricted Stock Units are Performance Awards and will become vested if and to the extent
the service and performance vesting conditions set forth in Section 2 are satisfied. To the extent so vested, each Restricted Stock Unit represents an unfunded, unsecured right of the Grantee to receive one Share at a specified time. 

 2. Vesting of Restricted Stock Units. 

(a) Performance Criteria. If the Grantee is continuously employed by the Company and/or its Affiliates through the “Settlement
Date” (as defined in Section 3), the Grantee will vest in such percentage of the Target Award based on the Company’s cumulative “Adjusted EBITDA” (as defined below) with respect to the Company’s
                     fiscal year through and including the Company’s
                     fiscal year (the “Performance Period”), as set forth in the following table: 

 

													
	 	  	Threshold Level	 	  	Target Level	 	  	Maximum Level	 
	 Cumulative Adjusted EBITDA
	  	$	             	  	  	$	             	  	  	$	             	  
	 Percent of Target Award Vested
	  	 
 	50% of Target
Award	  
  	  	 
 	100% of Target
Award	  
  	  	 
 	150% of Target
Award	  
  

 The Committee will interpolate to determine the Restricted Stock Units vested for all levels of cumulative Adjusted EBITDA
above the Threshold Level but below the Maximum Level. Notwithstanding the foregoing, if the Company’s Adjusted EBITDA for the
                     fiscal year does not equal or exceed $            , all of
Grantee’s Restricted Stock Units will be forfeited with no further compensation due to Grantee. Additionally, if cumulative Adjusted EBITDA is below the Threshold Level, all of Grantee’s Restricted Stock Units will be forfeited with
no further compensation due to Grantee. 
 (b) Definition of Adjusted EBITDA. Adjusted EBITDA shall mean the Company’s earnings
before interest, taxes, depreciation and amortization, as reflected in the Company’s financials, adjusted to exclude the impact of (a) loss on impairment of tangible or intangible assets; (b) gain or loss on disposal of assets;
(c) gain or loss from the early extinguishment, redemption or repurchase of debt, and (d) stock-based compensation expense. “Adjusted EBITDA” will also be adjusted to exclude (i) the impact of any changes to accounting
principles that become effective during the Performance Period, (ii) any expenses incurred by the Company in connection with the Company’s evaluation, pursuit or consummation of one or more strategic alternatives or transactions (which
such expenses are considered to be incurred in connection with extraordinary, unusual or infrequently occurring events reported in the Company’s public filings), and (iii) any expenses incurred by the Company in connection with the
relocation of its corporate headquarters and distribution center facilities (which such expenses are considered to be incurred in connection with extraordinary, unusual or infrequently occurring events reported in the Company’s public filings).
Additionally, the Committee reserves the right, in its sole judgment, to utilize negative discretion to make equitable adjustments to Adjusted EBITDA with respect to extraordinary, unusual or infrequently occurring events and/or acquisitions or
dispositions by the Company of any entity or line of business (or acquisitions or dispositions of all or substantially all of the assets of an entity or line of business) that occur during the Performance Period. 

(c) Change in Control. If a Change in Control occurs during the Performance Period and the Grantee is continuously employed by the
Company and/or its Affiliates through the date of that Change in Control, the Grantee will vest in the Restricted Stock Units at the Target Level and, and in full settlement of his or her rights hereunder, will receive a distribution of the Shares
underlying such Restricted Stock Units immediately prior to but contingent upon such Change in Control. In addition, upon a Change in Control, the Committee reserves the right, on a case by case basis, to increase the vested Restricted Stock Units
from the Target Level to the Maximum Level or to any other amount in between those levels. For avoidance of doubt, this paragraph will not limit the right of the Board to take other action with respect to the Restricted Stock Units under
Section 3(d)(vi) of the Plan upon the occurrence of any Change in Control. 

  
 -2- 

 (d) Certain Terminations of Service. If the Grantee’s employment with the Company and
its Affiliates is terminated prior to distribution of Shares in respect of vested Restricted Stock Units (i) due to the Grantee’s death, (ii) due to the Grantee becoming Disabled, (iii) by the Company without “Cause” or
(iv) by the Grantee for “Good Reason” (as such terms are defined in the employment agreement between the Company and the Grantee), then notwithstanding such termination of employment, the Grantee will vest in a number of the
Restricted Stock Units equal to that number of Restricted Stock Units that would otherwise have vested in accordance with Section 2(a) above (i.e., based on the actual performance of the Company through the end of the Performance Period),
pro-rated in a ratio equal to the full number of completed days of the Grantee’s employment with the Company or its Affiliates in the Performance Period over 1095. Any remaining Restricted Stock Units that do not then vest will be forfeited
with no further compensation due to Grantee. If the Grantee’s employment with the Company and its Affiliates terminates or is terminated for any other reason prior to the Settlement Date, all of the Grantee’s the Restricted Stock Units
will be forfeited immediately with no further compensation due to Grantee. The foregoing treatment upon the termination of the Grantee’s employment with the Company and its Affiliates during the Performance Period will supersede any contrary
treatment in any presently existing employment agreement between the Company and the Grantee. 
 3. Settlement. Except as
otherwise provided above in Section 2(c), the Committee will certify the performance results, and the resulting number of vested Restricted Stock Units, promptly following the end of the Performance Period. Shares will be distributed to the
Grantee in respect of vested Restricted Stock Units within 2 1⁄2 months following the end of the Performance Period (the “Settlement Date”).

 4. Non-Transferability. Neither the Restricted Stock Units nor any right with respect thereto may be assigned, alienated,
pledged, attached, sold or otherwise transferred or encumbered by the Grantee other than by will or by the laws of descent and distribution, and any purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance will be void and
unenforceable.  
 5. Rights of Grantee During Restricted Period. The Grantee will not have any stockholder rights or
privileges, including voting rights, with respect to the Shares underlying the Restricted Stock Units until such Shares are delivered to the Grantee. Notwithstanding the foregoing, if the Company declares and pays a cash dividend or distribution
with respect to its Shares prior to the Settlement Date, the Restricted Stock Units then subject hereto will be increased by a number of additional Restricted Stock Units determined by dividing (A) the total dividend or distribution that would
then be payable with respect to a number of Shares equal to the number of Restricted Stock Units subject hereto on the dividend or distribution record date (including any additional Restricted Stock Units previously credited pursuant to this
paragraph), divided by (b) the Fair Market Value on the dividend or distribution record date. Additional Restricted Stock Units credited under this paragraph will be subject to the same terms and conditions (including the same performance
vesting and settlement) as the Restricted Stock Units subject hereto immediately prior to such dividend or distribution.  
 6.
Securities Laws. The Board may from time to time impose any conditions on the Restricted Stock Units or the Shares underlying such award, as it deems necessary or advisable to ensure that the Shares are issued and resold in compliance
with the Securities Act of 1933, as amended. 

  
 -3- 

 7. Tax Consequences. The Grantee acknowledges that the Company has not advised the
Grantee regarding the Grantee’s income tax liability in connection with the grant, vesting or settlement of the Restricted Stock Units. The Grantee has had the opportunity to review with his or her own tax advisors the federal, state and local
tax consequences of the transactions contemplated by this Agreement. The Grantee is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Grantee understands that the Grantee (and not
the Company) shall be responsible for the Grantee’s own tax liability that may arise as a result of the transactions contemplated by this Agreement.  

8. The Plan. This Award of Restricted Stock Units is subject to, and the Grantee agrees to be bound by, all of the terms and
conditions of the Plan, as such Plan may be amended from time to time in accordance with the terms thereof. Pursuant to the Plan, the Board is authorized to adopt rules and regulations not inconsistent with the Plan as it shall deem appropriate and
proper. A copy of the Plan in its present form is available for inspection during business hours by the Grantee at the Company’s principal office. All questions of the interpretation and application of the Plan and the Grantee shall be
determined by the Board and any such determination shall be final, binding and conclusive.  
 9. Entire Agreement.
This Agreement, together with the Plan, represents the entire agreement between the parties hereto relating to the subject matter hereof, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every
nature. 
 10. No Right to Continued Employment. Neither the Plan nor this Agreement shall be construed as giving the
Grantee the right to be retained in the employ of, or in any consulting relationship with, the Company or any of its Affiliates. Further, the Company (or, as applicable, its Affiliates) may at any time dismiss the Grantee, free from any liability or
any claim under the Plan or this Agreement, except as otherwise expressly provided herein.  
 11. Electronic Delivery of
Documents. The Grantee hereby authorizes the Company to deliver electronically any prospectuses or other documentation related to this Award, the Plan and any other compensation or benefit plan or arrangement in effect from time to time
(including, without limitation, reports, proxy statements or other documents that are required to be delivered to participants in such plans or arrangements pursuant to federal or state laws, rules or regulations). For this purpose, electronic
delivery will include, without limitation, delivery by means of e-mail or e-mail notification that such documentation is available on the Company’s Intranet site. Upon written request, the Company will provide to the Grantee a paper copy of any
document also delivered to the Grantee electronically. The authorization described in this paragraph may be revoked by the Grantee at any time by written notice to the Company. 

12. Tax Withholding. The Company hereby agrees that, at the election of the Grantee and except as would otherwise violate the
terms of any financing agreement to which the Company is then a party, the minimum required tax withholding obligations arising in connection with this Award may be settled by withholding the delivery of nonforfeitable Shares otherwise distributable
hereunder in respect of vested Restricted Stock Units based on the Fair Market Value of those Shares. 

  
 -4- 

 13. Governing Law. This Agreement will be construed in accordance with the laws of
the Commonwealth of Pennsylvania, without regard to the application of the principles of conflicts of laws. 
 14.
Amendment. Subject to the provisions of the Plan, this Agreement may only be amended by a writing signed by each of the parties hereto. 

15. Execution. This Agreement may be executed, including execution by facsimile signature, in one or more counterparts, each of
which will be deemed an original, and all of which together shall be deemed to be one and the same instrument. 
 [This space left
blank intentionally; signature page follows.] 

  
 -5- 

 IN WITNESS WHEREOF, the Company’s duly authorized representative and the Grantee have each
executed this Restricted Stock Unit Award Agreement on the respective date below indicated. 
  

			
	DESTINATION MATERNITY CORPORATION
		
	By:		  

		
	Name:		
		
	Title:		
		
	Date:		
	
	GRANTEE
		
	Signature:		  

		
	Date:		

  
 -6-EX-10.1

 Exhibit 10.1 
  

 
 ENGAGEMENT AGREEMENT 

April 3, 2015 
 Dr. Yuichi Iwaki 

Chief Executive Officer 
 MediciNova, Inc. 

4275 Executive Square, Suite 650 
 San Diego, CA 92037 

Dear Dr. Iwaki, 
 This agreement (together with all
attachments hereto, the “Agreement”) is made effective April 3, 2015 and confirms the engagement of van den Boom & Associates, LLC (“we” or “van den Boom”) to assist MediciNova, Inc.
(“MediciNova”, “the Company” or “management”) with general accounting services. 
 Services: 

The objective of van den Boom’s services is to assist MediciNova’s management with general accounting services. Services to be provided include but
are not limited to: 
  

	 	•	 	Provide an Chief Financial Officer level resource to assist with Finance Department oversight including, but not limited to, reviewing accounting records, coordinating and assisting auditors, budgeting, treasury,
Sarbanes Oxley oversight and drafting and reviewing financial statements 

  

	 	•	 	Provide an Senior Accountant/Controller level resource to assist with day-to-day accounting functions including, but not limited to, preparing and reviewing accounting records, drafting financial statements,
coordinating and assisting auditors 

 Project team: 

The bios of the associates we are proposing to assist MediciNova are included in Attachment A. Although we do not anticipate changes to this team, we do
reserve the right to replace a consultant with an equally qualified consultant, if necessary. We do not anticipate that each of these consultants will be assigned to this project on a full time basis. 

Fees and Billing: 
 van den Boom will bill MediciNova
based on work performed at the following rates: 
  

					
	 Senior Accountant Resource
		$	135/hr	  
	 Controller Resource
		$	150/hr	  
	 CFO Resource
		$	250/hr	  

 In the event of an audit, investigation, or other proceeding, relating to MediciNova’s business records by a third party,
van den Boom will use commercially reasonable efforts to assist MediciNova, at its then prevailing hourly rates. 
  

  

			
	van den Boom & Associates, LLC		
	 3525 Del Mar Heights Rd. #316
 San
Diego, CA 92130
		 esther@vandenboomassociates.com

(619) 665.2478 phone

 No Solicitation for Employment: 

MediciNova recognizes that during the course of business, MediciNova will come in contact with van den Boom employees and contractors
(“staff”). MediciNova further recognizes and agrees that van den Boom has made a considerable investment in its staff. Therefore, during the term of this agreement and for a period of six months thereafter, MediciNova shall not
solicit the employment, employ, engage as a consultant, or engage in any other capacity, the services of any person who is then or was within the immediate preceding six months a staff of van den Boom. In addition to other remedies available in
law or in equity, MediciNova agrees that for each individual employed or engaged by MediciNova in violation of this Agreement, MediciNova shall pay to van den Boom liquidated damages of an amount equal to 50% of the Van den Boom staffs’ annual
salary or compensation.
 Permission to Use Logo or Registered Mark: 

MediciNova by and through its undersigned authorized representative, hereby gives permission for van den Boom to publish and/or use its company logo or
registered mark and/or company name for reasonable purposes connected with the business of van den Boom on behalf of the Company. It is also understood that van den Boom may use said logo or mark and/or name as a reference for advertising relating
to van den Boom’s services and portfolio of clients. The Company hereby releases van den Boom from all liability relating to the publication or use of the logo/mark and/or the company’s name. 

Confidentiality: 
 van den Boom agrees to maintain in
confidence and not disclose or use any proprietary information or know-how belonging to MediciNova. 
 Termination: 

The term of this agreement is intended to be through March 31, 2016 at which time a new engagement agreement must be executed. Either party may terminate
the services arrangement between van den Boom and MediciNova (i) upon 30 days advance written notice to the other party or (ii) immediately upon a material breach of this Agreement by the other party and a failure by the other party to
cure such breach within 10 days of written notice thereof by the non-breaching party to the breaching party. Upon any termination of the services or this Agreement, the Company shall pay van den Boom for all work-in-progress, services already
performed and expenses incurred by us up to and including the effective date of such termination. 
 To the extent that van den Boom agrees to perform
services for a subsequent fiscal year, the terms and conditions set forth in this Agreement shall apply to the performance of such services, except as specifically modified, amended or supplemented in writing by the parties. Changes in the scope of
the services and estimated fees for such services in subsequent fiscal years will be communicated in supplemental agreements. 

  

			
	van den Boom & Associates, LLC		
	 3525 Del Mar Heights Rd. #316
 San
Diego, CA 92130
		 esther@vandenboomassociates.com

(619) 665.2478 phone

 Indemnification: 

MediciNova shall indemnify and hold harmless van den Boom and its officers, directors, shareholders, partners, members, managers, agents, employees and
affiliates from any and all claims, costs, expenses or liabilities, including, but not limited to, attorneys’ fees, arising from or in any manner connected with any and all acts performed by van den Boom on behalf of MediciNova pursuant to the
terms of this engagement agreement and for any acts or decisions made in good faith while performing services for MediciNova pursuant to this engagement agreement; provided, however, that van den Boom shall not be entitled to indemnity for any
claims related to negligence or misconduct on the part of van den Boom and its officers, directors, shareholders, partners, members, managers, agents, employees and affiliates. 

van den Boom appreciates the opportunity to be of assistance to the Company. If this Agreement accurately reflects the terms on which the Company has agreed
to engage van den Boom, please sign below on behalf of the Company and return it to Esther van den Boom, 3525 Del Mar Heights Rd. #316, San Diego, CA 92130. 

Very truly yours, 
  

			
	 /s/ Esther van den Boom

	Esther van den Boom
	Owner, van den Boom & Associates LLC
	
	Agreed to and accepted on behalf of:
	MediciNova, Inc.
		
	By:		   /s/ Yuichi Iwaki

	Dr. Yuichi Iwaki
	Chief Executive Officer

  

			
	van den Boom & Associates, LLC		
	 3525 Del Mar Heights Rd. #316
 San
Diego, CA 92130
		 esther@vandenboomassociates.com

(619) 665.2478 phone

 ATTACHMENT A 

Esther van den Boom, CPA - CFO 
 Esther brings over
fourteen years of accounting and auditing experience to vdB&A. Esther assists companies in many capacities including CFO, technical accounting, IPO assistance, and SOX 404 implementations and compliance. Prior to starting vdB&A, Esther
worked with Ernst & Young LLP as a Senior Manager in their San Diego office’s audit practice where she gained extensive experience working with public companies both in the biotechnology and technology industries assisting them with
SEC filings and registrations, complex accounting and auditing matters such as revenue recognition, product launches, debt and equity transactions, complex valuations and implementation of SOX 404. In addition to extensive public company experience,
Esther has worked closely with many early stage, venture backed companies, including working with several through their successful transition to a public company. Prior to joining Ernst & Young’s audit practice, Esther worked with
Ernst & Young’s internal audit practice where she assisted clients with their SOX 404 implementations, including process documentation, identifying and designing key controls, and test and remediation. Esther received a B.A. in
Economics from University of California, San Diego and a M.S. in Accountancy from San Diego State University and is a licensed CPA. 
 John O’Neil,
CPA - Controller 
 John is a licensed CPA who assists our clients with their general accounting, including financial reporting, technical
accounting and day to day operations, as well as SOX 404 implementations and compliance. Prior to joining vdB&A, John worked with Ernst & Young LLP in the San Diego assurance practice where he was responsible for performing risk
assessment, planning, and management of financial statement audits. John’s clients have ranged in size from closely held, venture capital backed start-up companies to billion dollar SEC registrants. John has served a variety of
industries including technology, biotechnology, real estate and software. John has experience with the IPO process, having helped several companies go public as well as evaluating compliance with SOX 404 including review of process
documentation, test of control effectiveness and evaluation of deficiencies. Prior to his employment with Ernst & Young, John worked for a local tax accounting firm in San Diego where he was responsible for the preparation
of corporate, partnership and personal income tax returns. John received a Bachelor’s degree in Accountancy from the University of San Diego. 

  

			
	van den Boom & Associates, LLC		
	 3525 Del Mar Heights Rd. #316
 San
Diego, CA 92130
		 esther@vandenboomassociates.com

(619) 665.2478 phone

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00243-of-00352.parquet"}]]